Business Context and Reporting Period
Company: Inovio Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 1, 2026
Event: Suspension and termination of the ATM Prospectus dated August 13, 2024, related to an "at-the-market" (ATM) offering program with Oppenheimer & Co. Inc.
Key Financial Metrics
This filing does not contain comprehensive financial statements (revenue, profit, cash flow, margins, or debt). It reports specific capital raising activity under the ATM program:
- Total Shares Issued (ATM Program): 1,319,644 shares of Common Stock.
- Total Gross Proceeds (ATM Program): $3.2 million (before deducting sales commissions and offering expenses).
- Current Status: No further sales of Common Stock will occur under the Sales Agreement until a new prospectus is filed.
Material Changes
The primary material change is the cessation of the Company's ability to sell shares under the existing ATM Prospectus effective April 1, 2026. The Sales Agreement with Oppenheimer & Co. Inc. remains in full force and effect, but the specific prospectus governing the sales has been suspended and terminated.
Guidance, Outlook, and Risks
Management Commentary: The Company notified the Sales Agent of the suspension to halt sales under the current prospectus. No new sales will occur until a replacement prospectus is filed.
Risks/Contingencies: The filing does not disclose specific risks or contingencies beyond the operational halt of the ATM offering. The Company retains the right to resume sales upon filing a new prospectus.
Investor Verification Checklist
- Verify the date and content of the new prospectus filing required to resume ATM sales.
- Confirm the current cash balance and liquidity position in the most recent 10-Q or 10-K, as this 8-K does not provide current cash flow data.
- Review the total outstanding share count to assess the dilution impact of the 1,319,644 shares sold under the program.
- Check for any subsequent filings regarding the status of the Sales Agreement with Oppenheimer & Co. Inc.